Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUMO1 | P63165 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 5/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.32 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.32 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.32 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.32 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.32 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2512344 | 1.00 | SUMO1 (0.36) | SUMO1PNPTYMSGRIA1GRIA2 | |
| SCHEMBL29512549 | 0.98 | SUMO1 (0.36) | SUMO1PNPTYMSGRIA1GRIA2 | |
| Phosphoric Acid SCHEMBL29051947 | 0.93 | PNP (0.33) | SUMO1PNPTYMS | |
| Phosphoric Acid SCHEMBL29134054 | 0.93 | PNP (0.33) | SUMO1PNPTYMS | |
| SCHEMBL17224029 | 0.93 | PNP (0.33) | SUMO1PNPTYMS | |
| SCHEMBL13719619 | 0.90 | SUMO1 (0.35) | SUMO1PNP | |
| Cytosine SCHEMBL23783514 | 0.87 | ADORA2A (0.34) | SUMO1PNPTYMS | |
| SCHEMBL16432349 | 0.87 | SUMO1 (0.33) | SUMO1PNP | |
| SCHEMBL29002023 | 0.87 | GAA (0.37) | PNP | |
| SCHEMBL542389 | 0.85 | PNP (0.37) | PNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 28556 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146294-A1 | METHODS TO ENRICH NUCLEOTIDE VARIANTS BY NEGATIVE SELECTION | GUARDANT HEALTH, INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | claimed |
| WO-2026107204-A1 | METHODS FOR ANALYZING LOW-DEPTH GENOME SEQUENCING DATA TO DETECT MINIMAL RESIDUAL DISEASE | GUARDANT HEALTH, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| US-12630866-B2 | Methods for analyzing nucleic acids | BIOMODAL LIMITED (GB) | 2026-05-19 | — | — | US | claimed |
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| CN-122038534-A | Construction method of DNA library with modified nucleotide and application thereof | 深圳华大智造科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026102110-A1 | INDIVIDUALIZED MRD ASSAY TYPE SELECTION TO MAXIMIZE PER PATIENT SENSITIVITY BASED ON COMPREHENSIVE TUMOR VARIANT PROFILING | GUARDANT HEALTH, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026102107-A1 | METHODS FOR DETECTING SOMATIC VARIANTS | GUARDANT HEALTH, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-1036578-A | NOVEL FLUOROPHOSPHONATE NUCLEOTIDE DERIVATIVES | MERRELL DOW PHARMA (US) | 1989-10-25 | — | — | CN | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| EP-0284549-A2 | Magnetic fluid compositions | Silica Gel Ges.mbH Absorptionstechnik, Apparatebau (DE) | 1988-09-28 | — | — | EP | claimed |
| CN-86106265-A | Method for producing mildew mycin | — | 1987-08-12 | — | — | CN | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |
| EP-0015584-A2 | Nucleotides, methods for their preparation and medicaments | Gauri, Kailash Kumar, Dr. Prof. (DE) | 1980-09-17 | — | — | EP | claimed |
| US-4115576-A | 5-HYDROXYMETHYLCYTOSINE, A B6 VITAMIN, NICOTINAMIDE OR NICOTINIC ACID | PENN NATHAR W | 1978-09-19 | — | — | US | claimed |
| US-4048316-A | Composition for antagonizing the narcotic effects of barbiturate addiction and withdrawal effects, and for treatment of barbiturate poisoning | PENN NATHAR W | 1977-09-13 | — | — | US | claimed |
| US-4029768-A | Composition for application to the animal brain for synthesis of brain components involved in the learning process, and method | PENN NATHAR W | 1977-06-14 | — | — | US | claimed |